Clinical TrialsSearch results
Number of results: 284
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant tumor in the pelvis (JIVROSG-0204)
- Symptomatic intrapelvic malignant tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)
- Unresectable hypervascular hepatocellular carcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- A phase II randomized trial in completely resected non-small cell lung cancer comparing paclitaxel / carboplatin with TS-1
- non-small cell lung cancer
- Nagoya City University thoracic oncology study group
- 2008-11-18
Other
- A Phase II study of Gefitinib as First-Line Treatment for Elderly Patients with Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.
- Non-Small-Cell Lung Cancer
- Central Japan Lung Study Group
- 2009-04-08
Other
- A phase II study of percutaneous osteoplasty for painful malignant bone tumor (JIVROSG-0703)
- Malignant vertebral and pelvic bone tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0702)
- Malignant lung tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of percutaneous radiofrequency ablation for malignant reanl tumor (JIVROSG-0701)
- malignant renal tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-04-22
Other
- A phase II study of stent therapy for malignant vena cava syndrome. (JIVROSG-0402)
- Malignant vena cava stenosis.
- Japan Interventional Radiology in Oncology Study Group(JIVROSG)
- 2005-08-07
Other
- A phase II study of the Cladribine and Rituximab combination therapy for relapsed and refractory indolent B-cell Non-Hodgkin's Lymphoma.
- low grade B cell lymphoma
- refractory lymphoma treatment study group
- 2008-12-18
Other
- A phase II trial of targeted busulfan and cyclophosphamide conditioning for allogeneic hematopoietic stem cell transplantation for hematological malignancies
- Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
- Nagoya Blood and Marrow Transplantation Group
- 2005-09-13